Viveve Medical Inc. (VIVE)

[ProfessorCUNY]

Yes, Carusso, I noticed the same thing-- differing stats.

I did research on Fidelity site and found a report of -.40 for the PE ratio. Their debt is .8 of their capitalization. So, as far as I can see, VIVEVE is still in beginning stage of the growth cycle. That is, research, production, and distribution. Apparently, they have a multitude of backers. The perfect formula for going deeply into debt and diluting the stock to pay off the insiders.

They just entered the South Korean market. Let's hope they can sell this contraption and appease their female customers, which is the research outcome.

I am confident that the management is dedicated and experienced.

Sentiment: Strong Buy